EconomicChina·Unpinned15 Oct 2026
Black mould and bugs reported at Chinese plants producing GLP-1 compounding agents
AI-summarized · Neutrality-checked
Not on the map
This event isn't on the map, but everything else — summary, consequences, sources — is unaffected.
US FDA inspectors documented unsanitary conditions, including black mould and insect activity, at two Chinese facilities that manufactured semaglutide and tirzepatide active ingredients for compounded versions of weight-loss drugs. At the Chengdu Shengnuo Biopharm plant, staff were observed hiding documentation and discarding product samples during the…
Loading full story…
Sources and context
Straits Times
NewspaperTrust ownedSingaporeStandards not yet verified
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.